ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bigunks
|
304 |
71K |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
304
|
71K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Bigunks
|
179 |
28K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
179
|
28K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Bigunks
|
179 |
28K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
179
|
28K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Bigunks
|
179 |
28K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
179
|
28K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Bigunks
|
77 |
17K |
9 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
77
|
17K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Bigunks
|
197 |
48K |
15 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
197
|
48K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bigunks
|
971 |
226K |
12 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
971
|
226K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Bigunks
|
323 |
71K |
14 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
71K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $3.5 Million at a Premium
|
|
Bigunks
|
60 |
13K |
8 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
60
|
13K
|
8
|
|
ASX - By Stock
|
LCL |
Re:
Ann: Trading Halt
|
|
Bigunks
|
13 |
3.0K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
13
|
3.0K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Questions for the AGM
|
|
Bigunks
|
19 |
3.8K |
11 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
19
|
3.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
Bigunks
|
125 |
23K |
4 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
23K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PHARMAUST 2023 AGM.
|
|
Bigunks
|
15 |
3.0K |
6 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
15
|
3.0K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
Bigunks
|
125 |
23K |
3 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
23K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification of expiry of quoted options
|
|
Bigunks
|
43 |
8.7K |
10 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
43
|
8.7K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, The New Dawn, September , Optober 2023
|
|
Bigunks
|
132 |
32K |
5 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
132
|
32K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
Bigunks
|
140 |
29K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
140
|
29K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Bigunks
|
396 |
79K |
6 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
396
|
79K
|
6
|
|
ASX - By Stock
|
VN8 |
Re:
No quarterly activities and cashflow report again
|
|
Bigunks
|
3 |
1.7K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
3
|
1.7K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Bigunks
|
396 |
79K |
12 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
396
|
79K
|
12
|
|
ASX - By Stock
|
WKT |
Re:
Ann: First Drawdown Senior Debt Facility
|
|
Bigunks
|
191 |
38K |
7 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
191
|
38K
|
7
|
|
ASX - By Stock
|
WKT |
Re:
Ann: First Drawdown Senior Debt Facility
|
|
Bigunks
|
191 |
38K |
22 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
191
|
38K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Bigunks
|
396 |
79K |
17 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
396
|
79K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Bigunks
|
51 |
11K |
20 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
51
|
11K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
|
|
Bigunks
|
68 |
15K |
9 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
68
|
15K
|
9
|
|
ASX - By Stock
|
WKT |
Re:
Ann: Invitation to Shareholder Roadshows
|
|
Bigunks
|
60 |
13K |
15 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
60
|
13K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Bigunks
|
205 |
41K |
13 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
205
|
41K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Bigunks
|
205 |
41K |
7 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
205
|
41K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Bigunks
|
205 |
41K |
7 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
205
|
41K
|
7
|
|
ASX - By Stock
|
WKT |
Re:
Ann: Application for quotation of securities - WKT
|
|
Bigunks
|
62 |
10K |
9 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
62
|
10K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Bigunks
|
127 |
27K |
9 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
127
|
27K
|
9
|
|
ASX - By Stock
|
LCL |
Re:
Ann: Trading Halt
|
|
Bigunks
|
10 |
2.3K |
1 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
10
|
2.3K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Interactive AGM Yes/No vote
|
|
Bigunks
|
87 |
12K |
8 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
87
|
12K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Bigunks
|
164 |
37K |
12 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
164
|
37K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD
|
|
Bigunks
|
153 |
40K |
5 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
153
|
40K
|
5
|
|
ASX - By Stock
|
SVG |
Re:
Ann: Annual Report to shareholders
|
|
Bigunks
|
2 |
865 |
7 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
2
|
865
|
7
|
|
ASX - By Stock
|
WKT |
Re:
Ann: Voluntary Suspension Extension Request
|
|
Bigunks
|
18 |
6.0K |
1 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
18
|
6.0K
|
1
|
|
ASX - By Stock
|
SVG |
Re:
Ann: Production Ramp Up Continues with Second Gold Pour
|
|
Bigunks
|
109 |
19K |
5 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
109
|
19K
|
5
|
|
ASX - By Stock
|
SVG |
Re:
Share price movement
|
|
Bigunks
|
131 |
31K |
6 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
131
|
31K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Bigunks
|
65 |
15K |
6 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
65
|
15K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine phase 2b cancer trial expands to New Zealand
|
|
Bigunks
|
32 |
7.2K |
6 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
32
|
7.2K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
Bigunks
|
42 |
6.2K |
5 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.2K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
Bigunks
|
42 |
6.2K |
6 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.2K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
Bigunks
|
42 |
6.2K |
2 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.2K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
Bigunks
|
42 |
6.2K |
4 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.2K
|
4
|
|
ASX - By Stock
|
LCL |
Re:
General Day to Day Banter
|
|
Bigunks
|
1.2K |
395K |
5 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
1.2K
|
395K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Limping Home
|
|
Bigunks
|
32 |
5.7K |
12 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
32
|
5.7K
|
12
|
|
ASX - By Stock
|
LCL |
Re:
Ann: Step out drilling delivers further extensions at Tesorito
|
|
Bigunks
|
47 |
19K |
18 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
47
|
19K
|
18
|
|
ASX - By Stock
|
LCL |
Re:
Ann: Step out drilling delivers further extensions at Tesorito
|
|
Bigunks
|
47 |
19K |
3 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
47
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem Completes Build of OHD Benchtop Flow Reactor
|
|
Bigunks
|
53 |
10K |
9 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
53
|
10K
|
9
|
|